Dr. Udo Kraushaar is Senior Principal Scientist, Scientific Coordinator for Next-Generation Cellular and Organotypic Assays, and Team Lead Electrophysiology at the NMI Natural and Medical Sciences Institute at the University of Tübingen. His scientific background is in neurophysiology, cellular electrophysiology and functional in vitro assay development. He has long-standing expertise in microelectrode array (MEA) recordings, manual patch clamp, calcium imaging and network-level analysis. His work covers primary and hiPSC-derived neuronal and cardiac models, including cardiomyocytes, organotypic preparations and application-oriented cellular test systems. He has contributed to the development and validation of electrophysiological and imaging-based assay platforms for human neuronal signalling, functional neurotoxicity, cardiac safety pharmacology, disease modelling and translational assay development. In addition to his scientific expertise, he brings extensive experience in publicly funded national and European R&D consortia, work-package leadership, customer-facing contract research, scientific reporting and the structured translation of complex experimental data into robust project outputs. He also serves as an independent expert for the European Commission in the evaluation of EU research proposals, including roles as evaluator, rapporteur and Vice Chair.
Dr. Udo Kraushaar is Senior Principal Scientist, Scientific Coordinator for Next-Generation Cellular and Organotypic Assays, and Team Lead Electrophysiology at the NMI Natural and Medical Sciences Institute at the University of Tübingen. His scientific background is in neurophysiology, cellular electrophysiology and functional in vitro assay development. He has long-standing expertise in microelectrode array (MEA) recordings, manual patch clamp, calcium imaging and network-level analysis. His work covers primary and hiPSC-derived neuronal and cardiac models, including cardiomyocytes, organotypic preparations and application-oriented cellular test systems. He has contributed to the development and validation of electrophysiological and imaging-based assay platforms for human neuronal signalling, functional neurotoxicity, cardiac safety pharmacology, disease modelling and translational assay development. In addition to his scientific expertise, he brings extensive experience in publicly funded national and European R&D consortia, work-package leadership, customer-facing contract research, scientific reporting and the structured translation of complex experimental data into robust project outputs. He also serves as an independent expert for the European Commission in the evaluation of EU research proposals, including roles as evaluator, rapporteur and Vice Chair.